These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

622 related items for PubMed ID: 21505063

  • 1. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.
    Sieuwerts AM, Mostert B, Bolt-de Vries J, Peeters D, de Jongh FE, Stouthard JM, Dirix LY, van Dam PA, Van Galen A, de Weerd V, Kraan J, van der Spoel P, Ramírez-Moreno R, van Deurzen CH, Smid M, Yu JX, Jiang J, Wang Y, Gratama JW, Sleijfer S, Foekens JA, Martens JW.
    Clin Cancer Res; 2011 Jun 01; 17(11):3600-18. PubMed ID: 21505063
    [Abstract] [Full Text] [Related]

  • 2. Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR.
    Sieuwerts AM, Kraan J, Bolt-de Vries J, van der Spoel P, Mostert B, Martens JW, Gratama JW, Sleijfer S, Foekens JA.
    Breast Cancer Res Treat; 2009 Dec 01; 118(3):455-68. PubMed ID: 19115104
    [Abstract] [Full Text] [Related]

  • 3. Global gene expression profiling of circulating tumor cells.
    Smirnov DA, Zweitzig DR, Foulk BW, Miller MC, Doyle GV, Pienta KJ, Meropol NJ, Weiner LM, Cohen SJ, Moreno JG, Connelly MC, Terstappen LW, O'Hara SM.
    Cancer Res; 2005 Jun 15; 65(12):4993-7. PubMed ID: 15958538
    [Abstract] [Full Text] [Related]

  • 4. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
    Pinzani P, Salvadori B, Simi L, Bianchi S, Distante V, Cataliotti L, Pazzagli M, Orlando C.
    Hum Pathol; 2006 Jun 15; 37(6):711-8. PubMed ID: 16733212
    [Abstract] [Full Text] [Related]

  • 5. Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.
    Pestrin M, Bessi S, Galardi F, Truglia M, Biggeri A, Biagioni C, Cappadona S, Biganzoli L, Giannini A, Di Leo A.
    Breast Cancer Res Treat; 2009 Dec 15; 118(3):523-30. PubMed ID: 19597704
    [Abstract] [Full Text] [Related]

  • 6. HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.
    Fehm T, Müller V, Aktas B, Janni W, Schneeweiss A, Stickeler E, Lattrich C, Löhberg CR, Solomayer E, Rack B, Riethdorf S, Klein C, Schindlbeck C, Brocker K, Kasimir-Bauer S, Wallwiener D, Pantel K.
    Breast Cancer Res Treat; 2010 Nov 15; 124(2):403-12. PubMed ID: 20859679
    [Abstract] [Full Text] [Related]

  • 7. A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients.
    Kim SJ, Masago A, Tamaki Y, Akazawa K, Tsukamoto F, Sato J, Ozawa T, Tsujino Y, Noguchi S.
    Breast Cancer Res Treat; 2011 Aug 15; 128(3):765-73. PubMed ID: 21630023
    [Abstract] [Full Text] [Related]

  • 8. Gene expression profiles of circulating tumor cells versus primary tumors in metastatic breast cancer.
    Onstenk W, Sieuwerts AM, Weekhout M, Mostert B, Reijm EA, van Deurzen CH, Bolt-de Vries JB, Peeters DJ, Hamberg P, Seynaeve C, Jager A, de Jongh FE, Smid M, Dirix LY, Kehrer DF, van Galen A, Ramirez-Moreno R, Kraan J, Van M, Gratama JW, Martens JW, Foekens JA, Sleijfer S.
    Cancer Lett; 2015 Jun 28; 362(1):36-44. PubMed ID: 25797316
    [Abstract] [Full Text] [Related]

  • 9. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
    Ignatiadis M, Xenidis N, Perraki M, Apostolaki S, Politaki E, Kafousi M, Stathopoulos EN, Stathopoulou A, Lianidou E, Chlouverakis G, Sotiriou C, Georgoulias V, Mavroudis D.
    J Clin Oncol; 2007 Nov 20; 25(33):5194-202. PubMed ID: 17954712
    [Abstract] [Full Text] [Related]

  • 10. Circulating tumor cells in patients with breast cancer: monitoring chemotherapy success.
    Ušiaková Z, Mikulová V, Pintérová D, Brychta M, Valchář J, Kubecová M, Tesařová P, Bobek V, Kološtová K.
    In Vivo; 2014 Nov 20; 28(4):605-14. PubMed ID: 24982230
    [Abstract] [Full Text] [Related]

  • 11. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
    Taback B, Chan AD, Kuo CT, Bostick PJ, Wang HJ, Giuliano AE, Hoon DS.
    Cancer Res; 2001 Dec 15; 61(24):8845-50. PubMed ID: 11751407
    [Abstract] [Full Text] [Related]

  • 12. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.
    Mostert B, Kraan J, Bolt-de Vries J, van der Spoel P, Sieuwerts AM, Schutte M, Timmermans AM, Foekens R, Martens JW, Gratama JW, Foekens JA, Sleijfer S.
    Breast Cancer Res Treat; 2011 May 15; 127(1):33-41. PubMed ID: 20379845
    [Abstract] [Full Text] [Related]

  • 13. Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
    Apostolaki S, Perraki M, Kallergi G, Kafousi M, Papadopoulos S, Kotsakis A, Pallis A, Xenidis N, Kalmanti L, Kalbakis K, Agelaki S, Kalykaki A, Stournaras C, Stathopoulos E, Georgoulias V, Mavroudis D.
    Breast Cancer Res Treat; 2009 Oct 15; 117(3):525-34. PubMed ID: 19016323
    [Abstract] [Full Text] [Related]

  • 14. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.
    Cohen SJ, Alpaugh RK, Gross S, O'Hara SM, Smirnov DA, Terstappen LW, Allard WJ, Bilbee M, Cheng JD, Hoffman JP, Lewis NL, Pellegrino A, Rogatko A, Sigurdson E, Wang H, Watson JC, Weiner LM, Meropol NJ.
    Clin Colorectal Cancer; 2006 Jul 15; 6(2):125-32. PubMed ID: 16945168
    [Abstract] [Full Text] [Related]

  • 15. Molecular signature detection of circulating tumor cells using a panel of selected genes.
    Gervasoni A, Monasterio Muñoz RM, Wengler GS, Rizzi A, Zaniboni A, Parolini O.
    Cancer Lett; 2008 May 18; 263(2):267-79. PubMed ID: 18262345
    [Abstract] [Full Text] [Related]

  • 16. Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells.
    Joosse SA, Hannemann J, Spötter J, Bauche A, Andreas A, Müller V, Pantel K.
    Clin Cancer Res; 2012 Feb 15; 18(4):993-1003. PubMed ID: 22228641
    [Abstract] [Full Text] [Related]

  • 17. Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer.
    Munzone E, Nolé F, Goldhirsch A, Botteri E, Esposito A, Zorzino L, Curigliano G, Minchella I, Adamoli L, Cassatella MC, Casadio C, Sandri MT.
    Clin Breast Cancer; 2010 Oct 01; 10(5):392-7. PubMed ID: 20920984
    [Abstract] [Full Text] [Related]

  • 18. mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.
    Mostert B, Sieuwerts AM, Bolt-de Vries J, Kraan J, Lalmahomed Z, van Galen A, van der Spoel P, de Weerd V, Ramírez-Moreno R, Smid M, Verhoef C, IJzermans JN, Gratama JW, Sleijfer S, Foekens JA, Martens JW.
    Mol Oncol; 2015 Apr 01; 9(4):920-32. PubMed ID: 25655581
    [Abstract] [Full Text] [Related]

  • 19. Clinical significance of circulating tumor cells in breast cancer patients.
    Tao M, Ma D, Li Y, Zhou C, Li Y, Zhang Y, Duan W, Xu X, Wang R, Wu L, Liu H.
    Breast Cancer Res Treat; 2011 Aug 01; 129(1):247-54. PubMed ID: 21512769
    [Abstract] [Full Text] [Related]

  • 20. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A, Mavroudis D, Perraki M, Apostolaki S, Vlachonikolis I, Lianidou E, Georgoulias V.
    Anticancer Res; 2003 Aug 01; 23(2C):1883-90. PubMed ID: 12820473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.